Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Engineered APOBEC3A deaminase variants for highly accurate and efficient cytosine base editing

PROVIDER: PRJNA1032216 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26528237_1.fastq.gz	Fastqsanger.gz
	SRR26528237_2.fastq.gz	Fastqsanger.gz
	SRR26528238_1.fastq.gz	Fastqsanger.gz
	SRR26528238_2.fastq.gz	Fastqsanger.gz
	SRR26528239_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 84

Similar Datasets

Project description:Engineered APOBEC3A deaminase variants for highly accurate and efficient cytosine base editing

| PRJNA938578 | ENA

Project description:Engineered APOBEC3A deaminase variants for highly accurate and efficient cytosine base editing

| PRJNA938162 | ENA

Project description:Engineered APOBEC3A deaminase variants for highly accurate and efficient cytosine base editing

| PRJNA937584 | ENA

Project description:Engineered APOBEC3A deaminase variants for highly accurate and efficient cytosine base editing

| PRJNA938580 | ENA

Project description:Engineered APOBEC3A deaminase for highly accurate cytosine base editing.

| PRJNA938523 | ENA

Project description:Engineered APOBEC3A deaminase for highly accurate cytosine base editing.

| PRJNA938572 | ENA

Project description:Engineered APOBEC3A deaminase for highly accurate cytosine base editing.

| PRJNA1042830 | ENA

Project description:Engineered APOBEC3A deaminase for highly accurate cytosine base editing.

| PRJNA938284 | ENA

Efficient C-to-T base editing in methylated region with human APOBEC3A

Project description:Base editors (BEs) shed new light on correcting disease-related T-to-C mutations. However, current rat APOBEC1-based BEs are less efficient in editing cytosines in highly-methylated regions or in GpC context. By screening a variety of APOBEC/AID deaminases, we showed that human APOBEC3A-conjugated BE and its engineered forms can mediate efficient C-to-T base editing in all examined contexts, including regions with high-methylation levels and GpC dinucleotides, which extends base editing scope.

2018-08-20 | GSE114999 | GEO

CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE]

Project description:CRISPR-guided DNA base editors enable the efficient installation of targeted single-nucleotide changes. Cytosine or adenine base editors (CBEs or ABEs), which are fusions of cytidine or adenosine deaminases to CRISPR-Cas nickases, can efficiently induce DNA C-to-T or A-to-G alterations in DNA, respectively. We recently demonstrated that both the widely used CBE BE3 (harboring a rat APOBEC1 cytidine deaminase) and the optimized ABEmax editor can induce tens of thousands of guide RNA-independent, transcriptome-wide RNA base edits in human cells with high efficiencies. In addition, we showed the feasibility of creating SElective Curbing of Unwanted RNA Editing (SECURE)-BE3 variants that exhibit substantially reduced unwanted RNA editing activities while retaining robust and more precise on-target DNA editing. Here we describe structure-guided engineering of SECURE-ABE variants that not only possess reduced off-target RNA editing with comparable on-target DNA activities but are also the smallest Streptococcus pyogenes Cas9 (SpCas9) base editors described to date. In addition, we tested CBEs composed of cytidine deaminases other than APOBEC1 and found that human APOBEC3A (hA3A) cytidine deaminase CBE induces substantial transcriptome-wide RNA base edits with high efficiencies. By contrast, a previously described “enhanced” A3A (eA3A) cytidine deaminase CBE or a human activation-induced cytidine deaminase (hAID) CBE induce substantially reduced or near background levels of RNA edits. In sum, our work describes broadly useful SECURE-ABE and -CBE base editors and reinforces the importance of minimizing RNA editing activities of DNA base editors for research and therapeutic applications.

2019-07-11 | GSE129893 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data